Open Access

Antithrombotic therapy in patients with transcatheter aortic valve implantation: Balancing risks with benefits.

Congress Session

About the speaker

Professor Jurrien M ten Berg

St Antonius Hospital, Nieuwegein (Netherlands (The))
16 presentations
0 follower

3 more presentations in this session

Welcome: The shifting risk/benefit balance of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation and cardiac interventions.

Speaker: Professor I. Van Gelder (Groningen, NL)

Thumbnail

Building the evidence base for cardiac interventions in non-valvular atrial fibrillation.

Speaker: Professor R. Lopes (Durham, US)

Thumbnail

Panel Q&A.

Thumbnail

Access the full session

Optimising oral anticoagulation for atrial fibrillation patients undergoing cardiac interventions in 2021: From evidence to practice

Speakers: Professor J. ten Berg, Professor I. Van Gelder, Professor R. Lopes
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

Welcome and introduction.

27 August 2021

ESC Premium Access

Lipoprotein(a): an emerging lipid risk factor – discussion.

27 August 2021

ESC Premium Access

Future treatments for lipoprotein(a).

27 August 2021

This platform is supported by

logo Novo Nordisk